Aids experts denounce vaccine trial

A LARGE-SCALE trial of an Aids vaccine has been denounced by leading British scientists as a waste of time and money because few, if any, of the 5,000 volunteers will benefit.

The trial, which began this week, will result in people at risk of Aids in 30 American cities being injected with a prototype vaccine made from a synthetic protein designed to mimic the outer coating of HIV.

VaxGen, a private biotechnology company based in San Francisco, has received approval from the US Food and Drug Administration to go ahead with the phase three trial, which is usually the last stage before going on sale. It is the first of more than 40 Aids vaccine trials to get this far in the testing procedure. It will be given to half of the volunteers, who are all considered at risk of HIV infection. The other half will be given a harmless placebo.

Neither the scientists nor the volunteers will know who has been given the vaccine and who has the placebo until the end of the 30-month experiment, when the infection rates of the two groups will be compared to see if the vaccine has prevented HIV transmission.

VaxGen said its vaccine is modelled on an HIV protein called gp120. This protein has been of interest to Aids researchers for nearly 15 years because of the possibility of it being used to make vaccines that will stimulate the body's immune defences to attack HIV.

Scientists this month completed the first detailed, three-dimensional images of the structure of gp120. However, the new findings suggest that the VaxGen vaccine will be unable to stimulate an effective immune response in the volunteers because it is too dissimilar to natural gp120.

Andrew McMichael, professor of immunology at Oxford University and one of Britain's leading experts in Aids vaccine research, said: "I think the leading immunologists and virologists in the field are pretty unanimous in their view. The likelihood that [the vaccine] is not going to do anything is quite high."

Professor McMichael said the reasons why the trial is going ahead are more to do with ``business and politics'' than with science.

The vaccine is supposed to work by stimulating a patient's antibodies to attack the gp120 protein on HIV. However, the natural protein and the synthetic vaccine are too different for this to work with any great effect, he said.

``On theoretical grounds the chances are low. But preliminary trials earlier this year suggested that some vaccinated people still became infected. So really there was quite good negative evidence that this was not an effective vaccine,'' he said.

The reservations about vaccines based on gp120 are shared by dozens of American Aids specialists who recently signed a letter to the journal Science supporting a decision not to begin trials until problems with the vaccine's potency can be resolved.

Attempts to develop an Aids vaccine have met with problems because of the unique nature of HIV. It mutates rapidly, even within one person, so evading the best efforts of a vaccine to stimulate effective immunity.

Albert Sabin, who pioneered the development of a polio vaccine, warned just before be died in 1993 that it would be virtually impossible for any Aids vaccine to work. The virus he said was also able to escape the immune defences by infecting the cells that are sent to destroy it.

Suggested Topics
PROMOTED VIDEO
Have you tried new the Independent Digital Edition apps?
News
ebooksAn evocation of the conflict through the eyes of those who lived through it
News
Angelina Jolie with her father Jon Voight
people
News
Bill Kerr has died aged 92
people
Sport
footballPremiership preview: All the talking points ahead of this weekend's matches
Arts and Entertainment
Warner Bros released a mock-up of what the new Central Perk will look like
tv'Friends' cafe will be complete with Gunther and orange couch
News
Keira Knightley poses topless for a special September The Photographer's issue of Interview Magazine, out now
people
Voices
The Ukip leader has consistently refused to be drawn on where he would mount an attempt to secure a parliamentary seat
voicesNigel Farage: Those who predicted we would lose momentum heading into the 2015 election are going to have to think again
Arts and Entertainment
Cara Delevingne made her acting debut in Anna Karenina in 2012
film Cara Delevingne 'in talks' to star in Zoolander sequel
News
i100
Sport
Mario Balotelli pictured in his Liverpool shirt for the first time
football
Life and Style
tech
Independent
Travel Shop
the manor
Up to 70% off luxury travel
on city breaks Find out more
santorini
Up to 70% off luxury travel
on chic beach resorts Find out more
sardina foodie
Up to 70% off luxury travel
on country retreats Find out more
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Java Developer - 1 year contract

£350 - £400 Per Day: Clearwater People Solutions Ltd: Our client based in Cent...

Junior Analyst - Graduate - 6 Month fixed term contract

£17000 - £20000 Per Annum Bonus, Life Insurance + Other Benefits: Clearwater P...

SAS Business Analyst - Credit Risk - Retail Banking

£450 - £500 per day: Orgtel: SAS Business Analyst, London, Banking, Credit Ris...

Project Manager - Pensions

£32000 - £38000 Per Annum Bonus, Life Insurance + Other Benefits: Clearwater P...

Day In a Page

Ukraine crisis: The phoney war is over as Russian troops and armour pour across the border

The phoney war is over

Russian troops and armour pour into Ukraine
Potatoes could be off the menu as crop pests threaten UK

Potatoes could be off the menu as crop pests threaten UK

The world’s entire food system is under attack - and Britain is most at risk, according to a new study
Gangnam smile: why the Chinese are flocking to South Korea to buy a new face

Gangnam smile: why the Chinese are flocking to South Korea to buy a new face

Seoul's plastic surgery industry is booming thanks to the popularity of the K-Pop look
From Mozart to Orson Welles: Creative geniuses who peaked too soon

Creative geniuses who peaked too soon

After the death of Sandy Wilson, 90, who wrote his only hit musical in his twenties, John Walsh wonders what it's like to peak too soon and go on to live a life more ordinary
Caught in the crossfire of a cyber Cold War

Caught in the crossfire of a cyber Cold War

Fears are mounting that Vladimir Putin has instructed hackers to target banks like JP Morgan
Salomé's feminine wiles have inspired writers, painters and musicians for 2,000 years

Salomé: A head for seduction

Salomé's feminine wiles have inspired writers, painters and musicians for 2,000 years. Now audiences can meet the Biblical femme fatale in two new stage and screen projects
From Bram Stoker to Stanley Kubrick, the British Library's latest exhibition celebrates all things Gothic

British Library celebrates all things Gothic

Forthcoming exhibition Terror and Wonder: The Gothic Imagination will be the UK's largest ever celebration of Gothic literature
The Hard Rock Café's owners are embroiled in a bitter legal dispute - but is the restaurant chain worth fighting for?

Is the Hard Rock Café worth fighting for?

The restaurant chain's owners are currently embroiled in a bitter legal dispute
Caribbean cuisine is becoming increasingly popular in the UK ... and there's more to it than jerk chicken at carnival

In search of Caribbean soul food

Caribbean cuisine is becoming increasingly popular in the UK ... and there's more to it than jerk chicken at carnival
11 best face powders

11 best face powders

Sweep away shiny skin with our pick of the best pressed and loose powder bases
England vs Norway: Roy Hodgson's hands tied by exploding top flight

Roy Hodgson's hands tied by exploding top flight

Lack of Englishmen at leading Premier League clubs leaves manager hamstrung
Angel Di Maria and Cristiano Ronaldo: A tale of two Manchester United No 7s

Di Maria and Ronaldo: A tale of two Manchester United No 7s

They both inherited the iconic shirt at Old Trafford, but the £59.7m new boy is joining a club in a very different state
Israel-Gaza conflict: No victory for Israel despite weeks of death and devastation

Robert Fisk: No victory for Israel despite weeks of devastation

Palestinians have won: they are still in Gaza, and Hamas is still there
Mary Beard writes character reference for Twitter troll who called her a 'slut'

Unlikely friends: Mary Beard and the troll who called her a ‘filthy old slut’

The Cambridge University classicist even wrote the student a character reference
America’s new apartheid: Prosperous white districts are choosing to break away from black cities and go it alone

America’s new apartheid

Prosperous white districts are choosing to break away from black cities and go it alone